PhytoHealth Corp. engages in the research and development, production, manufacture, and sale of pharmaceutical drugs, cosmetics, Class B drugs, and dietary supplements. It operates through the following segments: Pharmaceutical Drug and Dietary Supplements, Medical Diagnostic Software, and Precision Medical Equipment. The Pharmaceutical Drug and Dietary Supplements segment is involved in the Chinese medicine and new pharmaceutical manufacture and sale. The Medical Diagnostic Software segment focuses on the development and sales of smart medical imaging diagnostic software devices. The Precision Medical Equipment segment develops, manufactures, and sells high-end ultrasonic probes. The company was founded by Chen Chia Lee on November 11, 1998 and is headquartered in Taipei, Taiwan.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company